A Barclays report on wealthy individuals worldwide notes that 47 percent of rich Chinese intend to move abroad in the next five years
More than a third of Americans are obese, but new pharmaceutical treatments have been slow to take off. Will Contrave figure out how to sell weight-loss drugs in the U.S.?
New data from the CDC show the increase in overdose deaths among whites far outpaced those among other races
The Android One starts at about $105
Calpers thinks hedge funds are too expensive and basically more trouble than they're worth. Could this be the start of a trend?
A business card with a brain can be customized for different recipients
"It's so much more than just a soda for many of us," says Evan Carr, the 26-year-old founder of the Surge Movement
The Consumer Financial Protection Bureau is suing Corinthian, a for-profit college operator, alleging abusive debt collection and deception
A report finds high default rates on franchise loans
Founders: Dr. Billy Hudson, Dr. Karl Tryggvason, and Dr. J. Wesley Fox
VC Investment over the last four quarters: $22 million
Founded in 2004, this eight-employee company develops innovative therapies for kidney disease. As for the recession, NephroGenex founders aren't daunted, and say that it will begin looking for a Big Pharma partner for its lead product next year.
Key to startup success: "If you are sure you have something that works and is useful to the marketplace, and others that you trust also agree, don't give up!"